New Delhi, July 9 (IANS) Using a combination of sodium-glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and kidney disease in patients with diabetes, according to a study. SGLT2is, also called gliflozins, are a class of drugs that lower blood glucose by increasing its excretion in the urine, while GLP-1RAs, such as Ozempic, work by enhancing insulin release and sensitivity. Impaired glucose control in patients with diabetes is known to cause damage to blood vessels in the heart and kidneys. According to lead author Brendon Neuen, Clinical Associate Professor from The George Institute
Hence then, the article about study shows how to protect diabetics from heart kidney disease was published today ( ) and is available onNews room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Study shows how to protect diabetics from heart & kidney disease )